Jiangxi Kvvit Pharmaceutical Co., Ltd.

This study tests a new cream called KR230109 in 180 people aged 18 to 40 with mild to moderate acne. Half will get the cream, half a placebo, and researchers will check if it reduces pimples and blackheads over 12 weeks. The goal is to see if the cream is safe and works better th…

This early-stage study is testing a new drug, KR23343, in 92 healthy adults aged 18 to 45. The goal is to check the drug's safety, how the body processes it, and whether food affects its absorption. Participants will receive either the drug or a placebo, and no direct health bene…